Before a drug reaches your pharmacy, it's been tested on cells, animals, and humans. But the real safety net is pharmaceutical toxicology. The US toxicology consulting market forecast shows that pharmaceutical companies are the largest end‑user segment, spending billions on safety assessments. Why? Because a single drug recall can cost $1 billion+ and destroy a company's reputation.

What do toxicologists do? They design studies to find the no‑observed‑adverse‑effect level (NOAEL), predict human doses, and flag potential carcinogens. The US toxicology consulting market analysis notes that regulatory advisory services are the fastest‑growing type, as companies navigate the shifting sands of FDA and EMA guidelines.

But there's a dark side: pressure to downplay risks. Some consultancies have been accused of data fishing — cherry‑picking results to get a drug approved. That's why regulators now require independent third‑party toxicology reviews.

The message: pharmaceutical toxicology is the unsung hero of modern medicine. Without it, we'd still be using thalidomide. But it's only as good as the integrity of the scientists doing the work.